Cellular Biomedicine Group, Inc. - OTCQB: CBMG


Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases.

We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory.

Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards.


19925 Stevens Creek Blvd. Suite 100
Cupertino, California 95014
United States

Get Directions

Upgrade Your Listing